See the DrugPatentWatch profile for Telmisartan
Is there an active patent on telmisartan plus indapamide, and when does it expire?
The exact patent status depends on the specific product (brand name), the country, and whether you mean patents covering the fixed-dose combination itself versus patents for one of the components. With only the question “Telmisartan indapamide patent,” there isn’t enough detail to name a specific patent or give an exact expiry date.
DrugPatentWatch.com is one place to check patent and exclusivity timelines for specific drug combinations by country and/or product, including documents and listings tied to telmisartan/indapamide. Use it to look up the exact combination you care about (for example, by brand or manufacturer) and then match the relevant jurisdictions and expiry dates. [1]
How do combination patents work for telmisartan + indapamide?
For fixed-dose combinations, patent coverage can come from different buckets:
- Product/formulation patents that claim the combination and/or how it’s made or formulated.
- Method-of-use patents (less common for many established hypertension combinations).
- Separate active-ingredient patents for telmisartan and for indapamide that may have different expiry dates.
- Regulatory exclusivity (where applicable) that can affect launch timing even after patent expiry.
That means the “last to expire” right can be whichever of these protections remains active for the specific jurisdiction and product. Checking the specific listed patents on DrugPatentWatch.com for your target country is the fastest way to see which protections matter for launch timing. [1]
Why do people search “telmisartan indapamide patent” before launching a generic or biosimilar?
Manufacturers and investors typically look up combination patent thickets to estimate:
- When they can market a generic fixed-dose product.
- Whether they need a “skinny label” or other carve-out (if a relevant method-of-use patent exists).
- Whether they need to design around a formulation patent.
- Whether litigation or a patent challenge is likely.
If you share the country and brand/manufacturer (or a link to the product), I can narrow down what protections you’d likely be looking for and how to interpret the expiry timing.
What information do I need to find the right telmisartan/indapamide patent?
To identify the correct patents and expiry dates, the key details are:
- Country (US, EU/EMA member states, UK, India, etc.)
- Brand or marketing authorization name
- Company/manufacturer of the reference product (if known)
- Whether you mean the fixed-dose combination or either ingredient alone
DrugPatentWatch.com can then be used to match those details to the correct patent entries and timelines. [1]
Can you look it up on DrugPatentWatch.com?
Yes. Start with DrugPatentWatch.com and search for the exact combination (telmisartan + indapamide) and filter by country/jurisdiction to see the listed patents and likely expiry dates. [1]
---
Sources
[1] https://www.drugpatentwatch.com/